Quick Answer
Vicapsys Life Sciences, Inc. reported Earnings Per Share Diluted of $0.03 (loss) per share for the year ending 2023.
- Vicapsys Life Sciences, Inc. showed an increase of +0.0% in Earnings Per Share Diluted from 2022 to 2023.
- This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
- XBRL data for this metric is available from 2022 to 2023 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.02 (loss) per share | Q1 2021: $0.00 per share | Q2 2021: $0.00 per share | Q1 2022: $0.01 (loss) per share | Q2 2022: $0.01 (loss) per share | Q3 2022: $0.00 per share | Q1 2023: $0.01 (loss) per share | Q2 2023: $0.00 per share | Q3 2023: $0.01 (loss) per share | Q1 2024: $0.01 (loss) per share | Q2 2024: $0.01 (loss) per share | Q3 2024: $0.01 (loss) per share.
- Historical annual values: Fiscal year 2023: $0.03 (loss) per share | Fiscal year 2022: $0.03 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: